Background: Nepal established the health partner coordination for COVID-19 response based on national and international plans and framework to support information-sharing for decision- making and course correction. This paper aims to assess the performance of COVID-19 Health Partner Coordination response in Nepal by adopting coordination best practices and tools from the international humanitarian cluster system.
Methods: Secondary data from unpublished documents on health partner coordination for COVID-19 response in Nepal was collected and analysed from April 2023 to May 2023. The secondary data were from the review of the health partner coordination meetings conducted for COVID-19 response using a researcher-developed document review tool, responses of health partners on a survey tool adapted from the cluster coordination performance monitoring tool from the Global Health Cluster, and transcript of Focused Group Discussion among health partners. Descriptive analysis of quantitative information and thematic analysis with predefined themes of qualitative information were performed using MS Excel and MS Word respectively. A written approval from the Ministry of Health and Population and an ethical clearance from the Nepal Health Research Council was obtained before conducting the study.
Results: More than three-fifths of the meetings showed good results in conduction, process, participation, and documentation of meeting action points with improvement required for follow-up (22.2%). Assessment of health partner coordination subfunctions resulted in either 'good' (>75.0%) or 'satisfactory' (50.1%-75.0%) except for prioritization based on analyses, which was 'unsatisfactory' (<50%). Partners admired good practices of health partner coordination, pointed out some issues, and provided recommendations.
Conclusion: COVID-19 has highlighted the importance of effective coordination of health sector for response to a pandemic. Continuation of this practice after addressing the areas for improvement will contribute to health preparedness and readiness for future disasters or public health emergencies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11482675 | PMC |
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0308941 | PLOS |
Prev Med Rep
January 2025
Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru.
Objective: Assess the association between having witnessed physical violence between parents and intimate partner violence (IPV) against men in Bolivian adults according to the Encuesta de Demografia y Salud (EDSA) 2016.
Methods: A retrospective cross-sectional study was conducted using data from the EDSA 2016 in Bolivia. The variable of interest in this study was IPV in men experienced during the last 12 months (any type of violence, physical and/or sexual, and psychological).
Background: Perceptions of disease risk play an important role in adopting healthy behaviors. The main objective of this study is to examine factors associated with high perceived cancer risk among Zuni Adults in New Mexico, USA.
Methods: We used data from a survey conducted in Zuni Pueblo from October 2020 to April 2021.
Health disparities in patients with pulmonary arterial hypertension (PAH) have not been extensively reported in the United States. The aim of this project was to characterize the extent of demographic and socioeconomic disparities in clinical outcomes within a large, diverse PAH patient population. A retrospective, population-based study of electronic health record data from the OneFlorida Data Trust was completed.
View Article and Find Full Text PDFFront Trop Dis
December 2024
Parasite and Vector Research Unit (PAVRU), Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.
Background: is transmitted by species and affects hundred millions of inhabitants in about 33 countries in sub-Saharan Africa. It is known that Mansonellosis due to do not result in a clear clinical picture, but down-regulates the immunity of patients predisposing them to other diseases like tuberculosis, HIV and malaria or damping vaccine efficacy. However, research about novel drugs against this filarial nematode is missing because of the lack of parasite material.
View Article and Find Full Text PDFMol Genet Metab Rep
March 2025
Alnylam Pharmaceuticals, Maidenhead, UK.
Background: Acute hepatic porphyria (AHP) is characterized by debilitating and potentially life-threatening neurovisceral attacks, possible chronic symptoms, and long-term complications. In a phase 1/2 open-label extension (OLE) study and the phase 3 ENVISION study, givosiran led to sustained improvement in annualized attack rate and quality of life (QOL) measures. To capture the patient experience of symptoms and impacts of AHP, and any changes experienced during treatment with givosiran, qualitative interviews were conducted with study participants.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!